|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 701 Pennsylvania Ave., NW Suite 720 |
Address2 | |
City | WASHINGTON |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 5632-12
|
||||||||
|
6. House ID# 312570000
|
TYPE OF REPORT | 8. Year | 2012 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Bob Walker - Head of Public Policy Communications |
Date | 01/18/2013 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ANI
16. Specific lobbying issues
H. R. 525 Veterinary Public Health Amendments Act. An act to amend the Public Health Service Act to enhance and increase the number of veterinarians trained in veterinary public health. Lobbied House and Senate
S 518 Veterinary Loan Repayment Program In support for legislation.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donna |
Stephens |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
HR 5973 FY 2013 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act. General provisions of the bill related to animal drugs and biologics.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donna |
Stephens |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAR
16. Specific lobbying issues
HR 5250/S 2763 To suspend temporarily the rate of duty on dimethyl carbonate polymer with 1,6 hexanediol copolymer and 2-oxepanone; (Provisions realted to the reduction of tariffs)
HR 5251/S 2765 To supsend temporarily the rate of duty on 1,6 hexanediol-dimethyl carbonate copoloymer; (Provisions realted to the reduction of tariffs)
HR5250/S 2767 To supsend temporarily the rate of duty on 1,6-Hexanediol-dimethyl carbonate copolymer; (Provisions related ot the reduction of tariffs.)
HR 5253/S 2770/S 2778 To supsend temporarily the rate of duty on reaction product of 3,5-dimethyl-1,2-diazole with polymer of hexane-1,6-diyl diisocyanate in organic solvent; (privisions related ot the reduction of tariffs.)
HR 5236/S 2772 To supsend temporarily the duty on Desmodur BL 1100/1; (Provisions related to the reduction of tariffs).
HR 5235/S 2773 To supsend temporarily the duty on on Bayhydur BL 5335; (Provisions related to the reduction of tariffs.)
HR 5233/S 2775 To supsend temporarily the duty on Desmodur VP LS 2078/2; (Provisions related to the reduction of tariffs.)
HR 5229/S 2779 To supsend temporarily the duty on 1,6-Diisocyanato-hexane homopolymer, polyethylene-polypropylene glycol mono-Bu ether blocked (Provision related to the reduction of tariffs.)
HR 5234/S 2781 To supsend temporarily the duty on Bayhydur XP 2547; (Provision related to the reduction of tariffs.)
HR 5246/S 2783 To extend the temporary suspension of duty on 2-Oxepanone polymer with 1,4-butanediol and 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane , 2-ethyl-1-hexanol-blocked; (Provisions related to the reduction of tariffs.)
HR 5247/S 2788 To extend and modify the temporary suspenion of dutry on Desmodur R-E; (Provisions related to the reduction of tariffs.)
HR 5230/S 2784 To extend the temporary suspension of duty on Desmodur E 14; (Provision related to the reduction of tariffs.)
HR 5248/S 2760 To extend and modify the temporary suspension of duty on Poly(toluene diisocyanate); (Provisions related to the reduction of tariffs.)
HR 5249/S 2762 To extend and modify the temporary suspension of duty on Desmodur RF-E; (Provisions related to the reduction of tariffs.)
HR 5231/S 2786 To extend and modify the temporary suspension of duty on Desmodur HL BA; (Provisions related to the reduction of tariffs.)
HR 5276/S 2758 To extend and modify the temporary reduction of duty on o-Acetylsalicylci acid (Aspirin); (Provision related to the reduction of tariffs.)
HR 5277/S 3028 To extend the temporary suspension of duty on D-Mannose; (Provisions related to the reduction of tariffs.)
HR 5278/S 3026 To extend the temporary suspension of duty on propoxur (2-(1-methylethoxy)phenol methlcarbamate); (Provisions related to the reduction of tariffs.)
S. 3292: Temporary Duty Suspension Process Act of 2012. Provisions related to tariffs (TAR)
Senate
H.R. 6727: United States Job Creation and Manufacturing Competitiveness Act of 2013. Provisions related to tariffs.
House
H.R.4459 and S. 2725: To suspend temporarily the duty on Thidiazuron.
H.R.4460 and S. 3135 : To extend the suspension of duty on Fenamidone.
H.R.4461 and S.2702 : To extend the suspension of duty on Spirodiclofen.
H.R.4462 and S.3137 : To extend the suspension of duty on 2,4-dichloroaniline.
H.R.4463 and S.2723: To suspend temporarily the duty on Thiacloprid.
H.R.4464 and S. 2700: To extend the suspension of duty on Pyrimethanil.
H.R.4465 : To suspend temporarily the duty on Pyrasulfotole.
H.R.4466 and S.2704: To suspend temporarily the duty on Fosetyl-Al.
H.R.4538 and S.3020 : To extend the temporary suspension of duty on Permethrin.
H.R.4575 : To modify and extend the temporary reduction of duty on Isoxaflutole.
H.R.4576 and S.3015 : To modify and extend the temporary reduction of duty on Clothianidin.
H.R.4578 and S. 3016: To supsend temporarily the duty on Triadimefon.
H.R.4657 : To suspend temporarily the duty on mixtures containing ?-cyfluthrin.
H.R.4658 : To extend the temporary reduction of duty on Deltamethrin.
H.R.4660 : To reduce temporarily the duty on Thiencarbazone-methyl.
H.R.4661 and S.3017: To extend the temporary suspension of duty on Spiromesifen.
H.R.4662 : To suspend temporarily the duty on Trifloxystrobin.
H.R.4663 and S. 2703: To modify and extend the temporary reduction of duty on 2-Acetylbutyrolactone.
H.R.4664 : To suspend temporarily the duty on 1,3-Cyclohexanedione.
H.R.4665 and S. 3132: To suspend temporarily the duty on Flubendiamide.
H.R.4666 and S.2722 : To suspend temporarily the duty on Spirotetramat.
H.R.4667 : To extend the temporary suspension of duty on Isoxadifen-Ethyl.
H.R.4668 and S. 3024: To extend the temporary suspension of duty on Cyfluthrin.
H.R.4669 : To modify and extend the temporary reduction of duty on ?-cyfluthrin.
H.R.4670 : To reduce temporarily the duty on mixtures contaning Trifloxystrobin and Prothioconazole.
H.R.4671 : To suspend temporarily the rate of duty on certain mixtures containing Trifloxystrobin.
H.R.4672 and S.2726 : To reduce temporarily the duty on mixtures containing Spirotetramat.
H.R.4673 : To suspend temporarily the duty on mixtures containing Trifloxystrobin and Propiconazole.
H.R.4675 and S. 2678: To reduce temporarily the duty on 1H-[1,2,4]Triazole.
H.R.4676 and S. 3161 : To suspend temporarily the duty on mixtures of Indaziflam.
H.R.4677 and S. 3162: To suspend temporarily the duty on mixtures of Flubendiamide.
H.R.4678 and S. 2681: To suspend temporarily the duty on mixtures containing Fluopyram.
H.R.4679 and S. 2719: To suspend temporarily the duty on mixtures containing Fluopyram and Prothioconazole.
H.R.4680 and S.2720: To suspend temporarily the duty on mixtures containing Fluopyram and Trifloxystrobin.
H.R.4681 and S.2721 : To suspend temporarily the duty on mixtures containing Fluopyram and Pyrimethanil.
H.R.4682 and S. 3133: To suspend temporarily the duty on Fenhexamid.
H.R.4683 and S.3134: To suspend temporarily the duty on Fluopicolide.
H.R.4684 and S 3130: To suspend temporarily the duty on Fluopyram.
H.R.4685 and S. 3131 : To suspend temporarily the duty on Indaziflam.
H.R.4686 and S. 3021 : To extend the temporary suspension of duty on 4-Chlorobenzaldehyde.
H.R.4687 and S.2701 : To extend the temporary suspension of duty on Phenmedipham.
H.R.4694 and S.3160 : To reduce temporarily the duty on product mixtures containing Spiromesifen.
H.R.4696 : To suspend temporarily the duty on product mixtures containing Clothianidin.
H.R.4698 : To extend the suspension of duty on product mixtures containing ethofumesate.
H.R.4699 : To suspend temporarily the duty on cyprosulfamide.
H.R.4735 and S.2355 : To extend and modify the temporary reduction of duty on ACM.
H.R.4736 and S.2356: To reduce temporarily the duty on Glufosinate-Ammonium (GA).
H.R.4737 and S.2354 : To extend and modify the temporary reduction of duty on Oxadiazon.
H.R.4876 and S. 3136: To extend the temporary reduction of duty on Imidacloprid.
H.R.4878 and S. 2587 : To suspend temporarily the duty on 1-Naphthyl, N-methylcarbamate.
H.R.4879 and S.2386 : To reduce temporarily the duty on Penflufen.
H.R.4883 and S. 2385 : To suspend temporarily the duty on IMIDACLOPRID.
H.R.4914 and S. 2680: To suspend temporarily the duty on mixtures containing Fluopyram and Tebuconazole.
H.R.5592 and S. 3023 : To suspend temporarily the duty on mixtures containing beta-cyfluthrin.
H.R.5591 and S. 3025
To modify and extend the temporary reduction of duty on beta-cyfluthrin.
H.R.4695 and S. 3008
To reduce temporarily the duty on product mixtures containing Clothianidin and Bacillus Firmus strain I-1582.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Juliane H. |
Van Egmond |
|
|
|
Dakotah |
Smith |
|
|
|
Jean |
Reimers |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
S 136 Ban Poisonous Additives Act of 2011- A bill to ban the use of bisphenol A in food containers, and for other purposes. All Provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.
HR 432-Ban Poisons Additives Act of 2011-A bill to ban Bis- phenol-A from all Food contact uses. All provisions related to banning Bisphenol-A.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Julie |
Van Egmond |
|
|
|
Dakotah |
Smith |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENG
16. Specific lobbying issues
H.R.840 : Safe Exploration Coming from Underwater Reserves of Energy Act or the SECURE Act Expedites drilling for oil or natural gas, if already permitted by the Minerals Management Service before May 3, 2010. Eliminates need for review by the Bureau of Ocean Energy Management, Regulation and Enforcement; and the National Environmental Policy Act of 1969 or any other similar statutes such as the Federal Water Pollution Control Act or the Marine Mammal Protection Act of 1972.
Provisions related to offshore drilling and exploration.
S 352- American Energy Independence and Security Act of 2011. A bill to allow leases and exploration of oil and gas from the coastal plain. All provisions related to increased supply of natural gas.
S.629 : A bill to improve hydropower, and for other purposes.
All provisions related to the advancement of alternative energy
S.630 : A bill to promote marine and hydrokinetic renewable energy research and development, and for other purposes. All provisions related to advancement of alternative energy
S.631 : A bill to extend certain Federal benefits and income tax provisions to energy generated by hydropower resources. All provisions related to provision of incentives for alternative power.
S398: A bill to increase energy efficiency and other purposes. The bill would reduce regulatory burden on appliance manufacturers, create energy and water savings and reduce the environmental impacts of energy production. All provisions related to enhancing energy efficiency.
H.R.2962 : Roofing Efficiency Jobs Act of 2011-a bill to amend the Internal Revenue Code to classify any qualified energy-efficient cool roof replacement property as 20-year property for depreciation purposes. All provisions related to incentives to retrofit or build cool roofs.
S.1575 : Energy-Efficient Cool Roof Jobs Act-a bill amend the Internal Revenue Code to classify any qualified energy-efficient cool roof replacement property as 20-year property for depreciation purposes. All provisions related to incentives in this bill
S.1737 Sensible Accounting to Value Energy Act of 2011 (SAVE Act) a bill to improve the accuracy of mortgage underwriting. All provisions related to the creation of energy efficiency retrofit and construction jobs, and for other purposes.
H.R.2599 : PACE Assessment Protection Act of 2011- a bill to prevent Fannie Mae, Freddie Mac, and other Federal residential and commercial mortgage lending regulators from adopting policies that go against State and local property clean energy laws.
All provisions related to the bill.
S. 3591, the Commercial Building Modernization Act (CBMA) introduced by Senators Snowe, Bingaman, Feinstein and Cardin. All provisions pertaining to extending and enhancing the tax reduction at Section 179D of the Internal Revenue Code for energy efficient commercial and multifamily buildings.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dakotah |
Smith |
|
|
|
Julie |
Van Egmond |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CHM
16. Specific lobbying issues
S 847 Safe Chemicals Act of 2011-A bill to modernize and extend the Toxic Substance Control Act of 1976. All provisions related to safety standard, testing, rules, listing, manufacturing, distribution and product stewardship.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Julie |
Van Egmond |
|
|
|
Dakotah |
Smith |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOM
16. Specific lobbying issues
S 709 Secure Chemical Facilities Act-a bill to insure adequate security is employed at chemical plants. All provisions related to chemical risk management, tiered assessments, audits, standard setting and inspections.
HR 908: Full Implementation of the Chemical Facilities Anti-Terrorism Act(CFATS) All provisions of the bill related to the reauthorization of CFATS through 2017
HR 5855 FY 2013 Homeland Security Appropriations Bill. Support for National Biodefense and Agriculture Facility funding.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Julie |
Van Egmond |
|
|
|
Dakotah |
Smith |
|
|
|
Donna |
Stephens |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
H.R. 872 and S 3605 Reducing Regulatory Burdens Act of 2011. Provisions related to NPDES permits
s. 3240 Agriculture Reform, Food, and Job ACt of 2012. Provisions related to NPDES permits
Farm Bill: Discussion of Farm Bill Extensions. Provisions related to NPDES, ESA, and Pollinators
Discussion of EPA regulatory actions involving pollinators protection and bee health.
S 1053 Veterinary Services Investment Act. General support of the bill.
H.R. 965 The Federal Food, Drug, Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases.
title II. General provisions in the bill
S 1211 Companion to above (HR 965)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jean |
Reimers |
|
|
|
Donna |
Stephens |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
H.R. 4223 the "Safe Doses Act"; H.R. 3668 the "Counterfeit Drug Penalty Enhancement Act of 2011"; and H.R. 4216 the "Foreign Counterfeit Prevention Act.", all parts
Combat Meth epidemic Act of 2005, sections pertaining to electronic reporting and stop sale
Meth Lab Elimination Act of 2010, a draft by Sen. Wyden, all parts relating to pseudoephedrine
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Thomas |
Lilburn |
|
|
|
Julie |
Corcoran |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
S. 365, Balanced Budget control Act of 2011, sections pertaining to healthcare expenditures, Medicare Part D drug benefits
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Thomas |
Lilburn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
7 |
|
||||||
2 |
|
8 |
|
||||||
3 |
|
9 |
|
||||||
4 |
|
10 |
|
||||||
5 |
|
11 |
|
||||||
6 |
|
12 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
Bayer MaterialScience LLC |
|
|
||||||||||||
Bayer HealthCare LLC |
|
|
||||||||||||
Bayer CropScience LP |
|
|
||||||||||||
Medred Inc. |
|
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 4 | 7 |
2 | 5 | 8 |
3 | 6 | 9 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 7 | 13 |
2 | 8 | 14 |
3 | 9 | 15 |
4 | 10 | 16 |
5 | 11 | 17 |
6 | 12 | 18 |